Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2449-2458

  Brossart, Peter ^a   Bevan, Michael J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PERFORIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BINDING AFFINITY; CELL KILLING; CYTOLYSIS; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD95; BASE SEQUENCE; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; FEMALE; H-2 ANTIGENS; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0029984048     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2449     Document Type: Article

References (41)

1. Germain, R.N. 1993. Antigen processing and presentation. In Fundamental Immunology. W.E. Paul, editor. Raven Press, New York. 629-676.
2. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
3. Sloan-Lancaster, J., and P.M. Allen. 1995. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:103-109.
4. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (Wash. DC). 252:1308-1310.
5. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 155:1047-1060.
6. Evavold, B.D., L.J. Sloan, B.L. Hsu, and P.M. Allen. 1993. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131-3140.
7. Mannie, M.D., J.M. Rosser, and G.A. White. 1995. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J. Immunol. 154:2642-2654.
8. Windhagen, A., C. Scholz, P. Hollsberg, H. Fukaura, A. Sette, and D.A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity. 2:373-380.
9. De Magistris, M.T., J. Alexander, M. Coggeshall, A. Altman, F.C.A. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:625-634.
10. Jameson, S.C., F.R. Carbone, and M.J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1541-1550.
11. Evavold, B.D., J. SJoan-Lancaster, and P.M. Allen. 1993. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc. Natl. Acad. Sci. USA. 91:2300-2304.
12. Rupper, J., J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H.M. Grey, and A. Sette. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc. Natl. Acad. Sci. USA. 90:2671-2675.
13. Spain, L.M., J.L. Jorgensen, M.M. Davis, and L.J. Berg. 1994. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J. Immunol. 152:1709-1717.
14. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27.
15. Ashton-Rickardt, P.G., A. Bandeira, J.R. Delaney, L. Van Kaer, H.-P Pircher, R.M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 76:651-663.
16. + T cells. Immunity. 3:79-86.
17. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
18. Vidal, K., and P.M. Allen. 1996. The effect of endogenous altered peptide ligands on peripheral T cell responses. Semin. Immunol. 8:117-122.
19. Nossal, G.J. 1994. Negative selection of thymocytes. Cell. 76: 229-239.
20. Fowlkes, B.J., and F. Ramsdell. 1993. T-cell tolerance. Curr. Opin. Immunol. 5:873-879.
21. Nanda, N.K., and E.E. Sercarz. 1995. Induction of anti-self-immunity to cure cancer. Cell. 82:13-17.
22. Steinman, L. 1995. Escape from "horror autotoxicus": pathogenesis and treatment of autoimmune disease. Cell. 80:7-10.
23. Hsu, B.L., B.D. Evavold, and P.M. Allen. 1995. Modulation of T cell development by an endogenous altered peptide ligand. J. Exp. Med. 181:805-810.
24. + T cells by a self-derived peptide. Nature (Lond.). 378:295-298.
25. Bellone, M., G. Iezzi, A.A. Manfredi, M.P. Protti, P. Dellabona, G. Casorati, and C. Rugarli. 1994. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur. J. Immunol. 24:2691-2698.
26. Grandea, A.G.3., and M.J. Bevan. 1992. Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides. Proc. Natl. Acad. Sci. USA. 89:2794-2798.
27. Ramsdell, F., M.S. Seaman, R.E. Miller, T.W. Tough, M.R. Alderson, and D.H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928-933.
28. Hahne, M., M.C. Peitsch, M. Irmler, M. Schroter, B. Lowin, M. Rousseau, C. Bron, T. Renno, L. French, and J. Tschopp. 1995. Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 7:1381-1386.
29. Schumacher, T.N.M., M.T. Heemels, J.J. Neefjies, W.M. Kast, C.J.M. Melief and H.L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell. 62:563-567.
30. Lynch, D.H., M.L. Watson, M.R. Alderson, P.R. Baum, R.E. Miller, T. Tough, M. Gibson, S.T. Davis, C.A. Smith, K. Hunter et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:131-136.
31. Ju, S.T., D.J. Panka, H. Cui, R. Ettinger, M. el Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (Lond.). 373:444-448.
32. Brossart, P., J.W. Schmier, S. Kruger, M. Willhauck, C. Scheibenbogen, T. Mohler, and U. Keilholz. 1995. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res. 55: 4065-4068.
33. + B cell hybridomas to H-2-restricted T cell hybridomas. Proc. Natl. Acad. Sci. USA. 79:3604-3607.
34. b. Science (Wash. DC). 257:919-927.
35. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA. 92:2479-2483.
36. Walsh, C.M., A.A. Glass, V. Chiu, and W.R. Clark. 1994. The role of the Fas lytic pathway in a perform-less CTL hybridoma. J. Immunol. 153:2506-2514.
37. Luciani, M.F., and P. Golstein. 1994. Fas-based d10S-mediated cytotoxicity requires macromolecular synthesis for effector cell activation but not for target cell death. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345:303-309.
38. McKeithan, T.W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92:5042-5046.
39. Madrenas, J., and R.N. Germain. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T cell activation. Sem. Immunol. In press.
40. Sloan, L.J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-z and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
41. Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain. 1995. z-Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (Wash. DC). 267:515-518.